Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis

Activation of antigen-specific T-lymphocyte responses may be needed to cure disorders caused by chronic infection with low-risk human papillomavirus (lrHPV). Safe and effective adjuvant therapies for such disorders are needed. The safety and efficacy of a novel gorilla adenovirus vaccine expressing...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Maxwell Y., Metenou, Simon, Brough, Douglas E., Sabzevari, Helen, Bai, Ke, Jochems, Caroline, Schlom, Jeffrey, Allen, Clint T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213691/
https://www.ncbi.nlm.nih.gov/pubmed/34145272
http://dx.doi.org/10.1038/s41541-021-00348-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213691/
https://www.ncbi.nlm.nih.gov/pubmed/34145272
http://dx.doi.org/10.1038/s41541-021-00348-x

Ejemplares similares